Skip to content

Application effect of nasal high-flow oxygen therapy in the sequential treatment of chronic obstructive pulmonary disease after non-invasive ventilation

Application effect of nasal high-flow oxygen therapy in the sequential treatment of chronic obstructive pulmonary disease after non-invasive ventilation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056867
Enrollment
Unknown
Registered
2022-02-21
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Interventions

Experimental group:Intranasal high-flow oxygen therapy was given during noninvasive ventilation intervals
Control group:Nasal catheter oxygen therapy was given during the interval of noninvasive ventilation

Sponsors

The People's Hospital of Yingshang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. AECOPD was diagnosed according to the Chinese expert Consensus on the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary Disease (AECOPD) (2017 update). The diagnosis was based on relevant medical history, physical examination, chest imaging and pulmonary function examination, etc.; 3. Mild to moderate acute hypercapnia, arterial blood gas 7.25 < pH < 7.35; 4. PaCO2 acuity 55 mm Hg.

Exclusion criteria

Exclusion criteria: 1. Tracheotomy; 2. Intubation or immediate intubation; 3. BMI>=30kg/m^2; 4. The pregnancy; 5. Agitated and uncooperative patients, RASS sedation score >=2; 6. Difficult to cough up sputum; 7. Unable to wear mask due to facial trauma; 8. Patients with hemodynamic instability; 9. Patients with hemoptysis, pneumothorax and severe pneumonia; 10. Multiple organ failure; 11. Unable to obtain informed consent.

Design outcomes

Primary

MeasureTime frame
Respiratory support time;Average daily duration of noninvasive ventilation use;Number of non-invasive ventilation intervals;

Countries

China

Contacts

Public ContactWang Xin

The People's Hospital of Yingshang

ysxrmyywx@126.com+86 15178120125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026